PT2399

13 Cited Publications
고객리뷰

Based on 13 publication(s) in Google Scholar

PT2399 is a selective and orally active HIF-2α antagonist (IC50 < 5 nM) that binds the PAS-B domain and disrupts HIF-2α-ARNT heterodimerization. PT2399 inhibits HIF-2α-driven transcription, destabilizes HIF-2α, and suppresses HIF target genes without inhibiting HIF1α. PT2399 reduces tumor cell proliferation, vessel area, circulating tumor-derived VEGFA/VEGF, and lactate while increasing pyruvate. PT2399 can be used for research on clear cell renal cell carcinoma and chronic myeloid leukemia (CML).

연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.

  • Purity : 99.96%
  • CAS No.: 1672662-14-4
  • 화학식: C17H10F5NO4S
  • 분자량:419.32
  • 보관:

    -20°C, stored under nitrogen

    * In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)

  • Biological Activity
  • Chemical Information
  • 용액&용해도
  • Protocol
  • 순도&문서
  • References
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

견적 받기 해외재고보유

Other size
견적 받기
Please select quantity
Amount: USD 0.00